That would be wonderful, but I have a vague recollection that PAA did an IP swap with UNSW to sure up their hold in MPL. They may have relinquished their ownership of Mucin and Abendazole in the process?
I am happy to be corrected here. Perhaps it is worth asking the company to clarify...
PharmAust MPL - Effectiveness against Cancer and COVID-19., page-65
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.010(4.65%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 20.5¢ | $113.4K | 540.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2623 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
20.5¢ |
Change
-0.010 ( 4.21 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 21.5¢ | 20.5¢ | 318787 | ||
| Last updated 15.38pm 04/06/2024 ? | |||||
| PAA (ASX) Chart |